Mitesco (MITI) Cash from Discontinued Operations (2015 - 2023)
Mitesco (MITI) reported Cash from Discontinued Operations of 268566.0 for Q4 2023, up 20.04% on a QoQ basis from 335881.0 in Q3 2023.
Mitesco (MITI) has 2 years of Cash from Discontinued Operations data on file, last reported at 268566.0 in Q4 2023.
- Quarterly Cash from Discontinued Operations changed N/A year-over-year to 268566.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was 268566.0 (up 47.95% YoY) and the FY2023 annual result came in at 698611.0, up 82.84% from the prior year.
- Cash from Discontinued Operations grew to 268566.0 in Q4 2023 per MITI's latest filing, from 335881.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 302802.0 in Q1 2023 and bottomed at 396966.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Mitesco | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -268,566.00 |
| Dec 31, 2023 | -268,566.00 |
| Sep 30, 2023 | -335,881.00 |
| Sep 30, 2023 | -335,881.00 |
| Jun 30, 2023 | -396,966.00 |
| Jun 30, 2023 | -396,966.00 |
| Mar 31, 2023 | 302,802.00 |
| Mar 31, 2023 | 302,802.00 |
| Jun 30, 2015 | 155,932.00 |
| Jun 30, 2015 | 155,932.00 |
| Mar 31, 2015 | -154,051.00 |
| Mar 31, 2015 | -154,051.00 |